{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:30:10Z","timestamp":1768440610093,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12928-025-01094-w","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T14:37:59Z","timestamp":1738593479000},"page":"352-361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Calcium channel blocker use and outcomes following transcatheter aortic valve intervention for aortic stenosis"],"prefix":"10.1007","volume":"40","author":[{"given":"Daisuke","family":"Miyahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-1479","authenticated-orcid":false,"given":"Masaki","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuki","family":"Yamaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikuni","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Kuwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro J.","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"1094_CR1","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"RM Carey","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of hypertension: a review. JAMA. 2022;328:1849\u201361.","journal-title":"JAMA"},{"key":"1094_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","volume":"388","author":"IC Van Gelder","year":"2016","unstructured":"Van Gelder IC, Rienstra M, Crijns HJ, Olshansky B. Rate control in atrial fibrillation. Lancet. 2016;388:818\u201328.","journal-title":"Lancet"},{"key":"1094_CR3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/eurheartj\/ehy811","volume":"40","author":"E Sorbets","year":"2019","unstructured":"Sorbets E, Steg PG, Young R, Danchin N, Greenlaw N, Ford I, et al. \u03b2-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study. Eur Heart J. 2019;40:1399\u2013407.","journal-title":"Eur Heart J"},{"key":"1094_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jacc.2019.05.055","volume":"74","author":"T Rodriguez-Gabella","year":"2019","unstructured":"Rodriguez-Gabella T, Catal\u00e1 P, Mu\u00f1oz-Garc\u00eda AJ, Nombela-Franco L, Del Valle R, Guti\u00e9rrez E, et al. Renin-angiotensin system inhibition following transcatheter aortic valve replacement. J Am Coll Cardiol. 2019;74:631\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"1094_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2020-001269","author":"T Saito","year":"2020","unstructured":"Saito T, Yoshijima N, Hase H, Yashima F, Tsuruta H, Simizu H, et al. Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry. Open Heart. 2020. https:\/\/doi.org\/10.1136\/openhrt-2020-001269.","journal-title":"Open Heart"},{"key":"1094_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12113742","author":"T Imamura","year":"2023","unstructured":"Imamura T, Narang N, Onoda H, Tanaka S, Ushijima R, Sobajima M, et al. Negative prognostic impact of mineralocorticoid receptor antagonist in elderly patients receiving TAVR. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12113742.","journal-title":"J Clin Med"},{"key":"1094_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610103351504","author":"M Packer","year":"1996","unstructured":"Packer M, O\u2019Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective randomized amlodipine survival evaluation study group. N Engl J Med. 1996. https:\/\/doi.org\/10.1056\/NEJM199610103351504.","journal-title":"N Engl J Med"},{"key":"1094_CR8","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145:e895\u20131032.","journal-title":"Circulation"},{"key":"1094_CR9","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"1094_CR10","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","volume":"83","author":"H Tsutsui","year":"2019","unstructured":"Tsutsui H, Isobe M, Ito H, Ito H, Lkumura K, Ono M, et al. JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure-digest version. Circ J. 2019;83:2084\u2013184.","journal-title":"Circ J"},{"key":"1094_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2019.09.007","volume":"298","author":"S Saeed","year":"2020","unstructured":"Saeed S, Mancia G, Rajani R, Parkin D, Chambers JB. Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: Relationship with all-cause mortality. Int J Cardiol. 2020;298:122\u20135.","journal-title":"Int J Cardiol"},{"key":"1094_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the american society of echocardiography. J Am Soc Echocardiogr. 2019;32:1\u201364.","journal-title":"J Am Soc Echocardiogr"},{"key":"1094_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jchf.2014.04.006","volume":"2","author":"W Ouwerkerk","year":"2014","unstructured":"Ouwerkerk W, Voors AA, Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and\/or heart failure hospitalization in patients with heart failure. JACC Heart Fail. 2014;2:429\u201336.","journal-title":"JACC Heart Fail"},{"key":"1094_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1161\/CIRCHEARTFAILURE.114.001301","volume":"7","author":"K Patel","year":"2014","unstructured":"Patel K, Fonarow GC, Ahmed M, Morgan C, Kilgore M, Love TE, et al. Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014;7:945\u201352.","journal-title":"Circ Heart Fail"},{"key":"1094_CR15","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ejhf.3044","volume":"25","author":"S Matsumoto","year":"2023","unstructured":"Matsumoto S, Kondo T, Yang M, Campbell RT, Docherty KF, Boer RA, et al. Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. Eur J Heart Fail. 2023;25:2202\u201314.","journal-title":"Eur J Heart Fail"},{"key":"1094_CR16","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European society of hypertension: endorsed by the international society of hypertension (ISH) and the european renal association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"1094_CR17","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1161\/HYP.0000000000000067","volume":"71","author":"DM Reboussin","year":"2018","unstructured":"Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic Review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:e116\u201335.","journal-title":"Hypertension"},{"key":"1094_CR18","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.ahj.2010.02.030","volume":"159","author":"M Gotzmann","year":"2010","unstructured":"Gotzmann M, Lindstaedt M, Bojara W, M\u00fcgge A, Germing A. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am Heart J. 2010;159:926\u201332.","journal-title":"Am Heart J"},{"key":"1094_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jcin.2012.12.124","volume":"6","author":"GY Perlman","year":"2013","unstructured":"Perlman GY, Loncar S, Pollak A, Gilon D, Alcalai R, Planer D, et al. Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance. JACC Cardiovasc Interv. 2013;6:472\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"1094_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.006308","author":"BR Lindman","year":"2017","unstructured":"Lindman BR, Otto CM, Douglas PS, Hahn RT, Elmariah S, Weissman NJ, et al. Blood pressure and arterial load after transcatheter aortic valve replacement for aortic stenosis. Circ Cardiovasc Imag. 2017. https:\/\/doi.org\/10.1161\/CIRCIMAGING.116.006308.","journal-title":"Circ Cardiovasc Imag"},{"key":"1094_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014020","volume":"8","author":"BR Lindman","year":"2019","unstructured":"Lindman BR, Goel K, Bermejo J, Beckman J, O\u2019Leary J, Barker CM, et al. Lower blood pressure after transcatheter or surgical aortic valve replacement is associated with increased mortality. J Am Heart Assoc. 2019;8: e014020.","journal-title":"J Am Heart Assoc"},{"key":"1094_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/heartasia-2017-010994","volume":"10","author":"BJ Klinkhammer","year":"2018","unstructured":"Klinkhammer BJ, Dyke CM, Haldis TA. The development or worsening of hypertension after transcatheter aortic valve replacement (TAVR) improves short-term and long-term patient outcomes. Heart Asia. 2018;10: e010994.","journal-title":"Heart Asia"},{"key":"1094_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jchf.2016.02.017","volume":"4","author":"JR Kapoor","year":"2016","unstructured":"Kapoor JR, Kapoor R, Ju C, Heidenreich PA, Eapen ZJ, Hernandez AF, et al. Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail. 2016;4:464\u201372.","journal-title":"JACC Heart Fail"},{"key":"1094_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jama.297.7.709","volume":"297","author":"GF Mitchell","year":"2007","unstructured":"Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA. 2007;297:709\u201315.","journal-title":"JAMA"},{"key":"1094_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00563-3","author":"BF Stewart","year":"1997","unstructured":"Stewart BF, Siscovick D, Lind BK, Gardin M, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol. 1997. https:\/\/doi.org\/10.1016\/S0735-1097(96)00563-3.","journal-title":"J Am Coll Cardiol"},{"key":"1094_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/heart.84.3.347","volume":"84","author":"B Iung","year":"2000","unstructured":"Iung B. Interface between valve disease and ischaemic heart disease. Heart. 2000;84:347\u201352.","journal-title":"Heart"},{"key":"1094_CR27","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","volume":"292","author":"SE Nissen","year":"2004","unstructured":"Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004;292:2217\u201325.","journal-title":"JAMA"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-025-01094-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-025-01094-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-025-01094-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T09:51:33Z","timestamp":1742032293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-025-01094-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s12928-025-01094-w","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Izumo is a consultant for Edwards Lifesciences and Abbott Medical Japan, and Dr. Kuwata is a consultant for Abbott Medical Japan. The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}